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Neurobiology of Disease
Stress-Induced Cocaine Seeking Requires a Beta-2
Adrenergic Receptor-Regulated Pathway from the Ventral
Bed Nucleus of the Stria Terminalis That Regulates CRF
Actions in the Ventral Tegmental Area
Oliver Vranjkovic, X Paul J. Gasser, Clayton H. Gerndt, David A. Baker, and John R. Mantsch
Department of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53201
The ventral bed nucleus of the stria terminalis (vBNST) has been implicated in stress-induced cocaine use. Here we demonstrate that, in
the vBNST, corticotropin releasing factor (CRF) is expressed in neurons that innervate the ventral tegmental area (VTA), a site where the
CRF receptor antagonist antalarmin prevents the reinstatement of cocaine seeking by a stressor, intermittent footshock, following
intravenous self-administration in rats. The vBNST receives dense noradrenergic innervation and expresses  adrenergic receptors
(ARs). Footshock-induced reinstatementwas prevented by bilateral intra-vBNST injection of the-2 AR antagonist, ICI-118,551, but not
the -1 AR antagonist, betaxolol. Moreover, bilateral intra-vBNST injection of the -2 AR agonist, clenbuterol, but not the -1 agonist,
dobutamine, reinstated cocaine seeking, suggesting that activation of vBNST-2 AR is both necessary for stress-induced reinstatement
and sufficient to induce cocaine seeking. The contribution of a-2 AR-regulated vBNST-to-VTA pathway that releases CRF was investi-
gated using a disconnection approach. Injection of ICI-118,551 into the vBNST in one hemisphere and antalarmin into the VTA of the
contralateral hemisphere prevented footshock-induced reinstatement, whereas ipsilateral manipulations failed to attenuate stress-
induced cocaine seeking, suggesting that -2 AR regulate vBNST efferents that release CRF into the VTA, activating CRF receptors, and
promoting cocaine use. Last, reinstatement by clenbuterol delivered bilaterally into the vBNST was prevented by bilateral vBNST pre-
treatment with antalarmin, indicating that -2 AR-mediated actions in the vBNST also require local CRF receptor activation. Under-
standing the processes through which stress induces cocaine seeking should guide the development of new treatments for addiction.
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Introduction
In many cocaine addicts, relapse to drug use is triggered by the
onset of craving in response to episodes of stress. Due to the
uncontrollable and often unavoidable nature of stress, its contri-
bution to relapse is particularly problematic when managing co-
caine addiction.
Using rodent reinstatement models, preclinical researchers
have begun to define the neurocircuitry that underlies stress-
induced relapse. One prominent pathway that has been impli-
cated consists of a dopaminergic projection from the ventral
tegmental area (VTA) to the medial prefrontal cortex, where do-
pamine D1 receptor activation increases the activity of a gluta-
matergic pathway to the nucleus accumbens that is critical for
cocaine seeking (Capriles et al., 2003; McFarland et al., 2004).
During stress, the VTA is regulated by the neuropeptide cortico-
tropin releasing factor (CRF; Wang et al., 2005), in part via
CRF-R1 receptors (Blacktop et al., 2011), to evoke cocaine
seeking.
The VTA receives inputs from brain regions involved in inte-
gration of the stress response, including those comprising the
“extended amygdala”: the nucleus accumbens shell, central
amygdala, and bed nucleus of the stria terminalis (BNST; Phillip-
son, 1979). Among these structures, the BNST, which serves as an
interface between stress and motivational/reward systems, ap-
pears to be particularly important for stress-induced cocaine
seeking, in that its inactivation prevents stress-induced reinstate-
ment in rodents (McFarland et al., 2004; Briand et al., 2010). A
subgroup of neurons projecting from the BNST to the VTA ex-
pressCRF (Rodaros et al., 2007) and thereforemay be responsible
for stress-induced increases in VTA CRF and CRF-dependent
cocaine seeking. However, CRF projections to the VTA from the
ventral BNST (vBNST), the subregion implicated in stress-
induced cocaine seeking (McFarland et al., 2004), have not been
described. The BNST, particularly the vBNST, receives dense
noradrenergic innervation (Phelix et al., 1992) and expresses 
adrenergic receptors (ARs; Cecchi et al., 2007), which have been
reported to regulate efferent projections (Nobis et al., 2011), in-
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cluding those that innervate the VTA (Dumont and Williams,
2004; Silberman et al., 2013). Both stress-induced reinstatement
(Erb and Stewart, 1999; Erb et al., 2001) and noradrenergic reg-
ulation of BNST efferents to the VTA (Silberman et al., 2013)
require BNST CRF receptor activation, suggesting that norepi-
nephrine in the BNST promotes local CRF release, thereby acti-
vating a second CRF-releasing pathway to the VTA.
Considering the important role for noradrenergic signaling in
stress-induced reinstatement in rodents (Erb et al., 2000; Man-
tsch et al., 2010) and craving in human cocaine-dependent pop-
ulations (Jobes et al., 2011), AR regulation of a vBNST-to-VTA
CRF-releasing pathway is a likely mechanism through which
stress promotes cocaine seeking. We have found that -2 AR
activation is both necessary and sufficient for stress-induced re-
instatement in mouse models (Vranjkovic et al., 2012). More-
over, it has been demonstrated that a mixture of -AR
antagonists, administered into the vBNST, prevents stress-
induced reinstatement (Leri et al., 2002). In this study, we dem-
onstrate direct CRF neuronal projections from the vBNST to the
VTA and examine the relationship between stress-induced -2
AR activation in the vBNST and CRF-R1 receptor-dependent
actions in the VTA that lead to cocaine seeking.
Materials andMethods
Subjects
Male Sprague Dawley rats (Harlan Laboratories)90-d-old at the time
of delivery (325 g) were used. Rats were housed singly in a temperature-
and humidity-controlled, Association for Assessment and Accreditation
of Laboratory Animal Care accredited facility under a 12 h light/dark
cycle (lights off at 07:00 h) and had access to food and water at all times,
except during the food training periods during which they were kept at
90% of their free-feeding body weight. All procedures were performed in
accordance with the NIH Guide for the Care and Use of Laboratory
Animals.
Drugs
Cocaine HCl was acquired from the National Institute on Drug Abuse
through its drug supply program. The selective -1 AR antagonist betax-
olol HCl, the selective -2 AR antagonist (-)-(isopropylamino)-1-[(7-
methyl-4-indanyl)oxy]butan-2-ol (ICI-118,551) HCl, the selective -1
AR agonist dobutamine HCl, the selective -2 AR agonist clenbuterol,
and the axonal transport inhibitor colchicine HCl were purchased from
Sigma-Aldrich. Cocaine was dissolved in bacteriostatic saline. Other
drugs were dissolved in sterile water. Colchicine was delivered intracere-
broventricularly in a volume of 2 l over a 5 min period. Intracranial
drug injections occurred in a volume of 0.2 l/side over a 1 min period.
Catheter and cannula implantation
For intravenous self-administration (SA) and reinstatement testing, rats
were implanted with catheters into the jugular vein under ketamine HCl
(100 mg/kg i.p.) and xylazine (2 mg/kg, i.p.) anesthesia, as described
previously (Blacktop et al., 2011), along with 11 mm 26-gauge guide
cannulae aimed at the vBNST (0.6 mm posterior to bregma; 3.5 mm
lateral to midline; 6.9 mm ventral to the skull surface at a 15° angle),
and/or the VTA (5.6 mm posterior to bregma; 2.2 mm lateral to midline;
6.9 ventral to the skull surface at a 12° angle) for intracranial injections.
The tips of the guide cannulae were aimed 0.5 mm above the target
injection sites.
Cocaine self-administration
Following a 2 week recovery from surgery, rats were trained to self-
administer cocaine (1.0 mg/kg/inf, i.v.) by pressing a response lever un-
der an FR1 schedule in a computer-interfaced operant conditioning
chamber (Med Associates) during daily 2 h sessions. During these ses-
sions, the active (front) lever was extended into the chamber and the
corresponding stimulus lightwas illuminated. Pressing this lever resulted
in a cocaine infusion (200l over 5 s), followed by a 25 s time-out period
during which the stimulus light was extinguished but the lever remained
extended. Responding on a second, inactive lever was recorded but had
no programmed consequences. Once stable SA under the FR1 schedule
was observed (15 infusions), the requirements for SA were gradually
increased until rats displayed stable responding under ta FR4 schedule
(10% variation from the mean over 3 sessions), at which time daily
access was increased to 6 h. Rat were permitted to self-administer daily
under these conditions for 14 consecutive days after which they under-
went extinction training.
Extinction training and reinstatement testing
Extinction sessions were identical to SA conditions except that (1) the
sessions were 2 h in duration and (2) the cocaine solution was replaced
with saline. Daily extinction training sessions were conducted until rats
displayed 15 cocaine lever responses for consecutive sessions (range,
6–10 d) at which time rats were tested for reinstatement. Reinstatement
sessions were identical to extinction sessions except that they were pre-
ceded by exposure to shock and/or intracranial drug delivery. Shocks (0.5
mA, 0.5 s duration) were delivered on average every 40 s (range, 10–70 s)
through the grid floors of the chambers over a 15min period that imme-
diately preceded the 2 h reinstatement test session (Blacktop et al., 2011;
Graf et al., 2011). During the shock session, the levers were retracted and
the stimulus lights were off, but a houselight in the chamber was illumi-
nated. Reinstatement was defined as an increase in cocaine lever re-
sponding relative to the prior extinction session. When rats were tested
multiple times for reinstatement, test sessions were separated by addi-
tional extinction session and were required to display15 cocaine lever
responses before retesting.
Effects on food-reinforced lever pressing
In most cases where significant reductions in shock-induced reinstate-
mentwere observed, the effects of the samemanipulations on lever press-
ing reinforced by food delivery (45 mg sucrose-sweetened food pellets;
BioServ) were also examined in separate rats to confirm that reduced
reinstatement was not attributable to motor impairment that interfered
with the ability of the rats to press the lever. Following surgical intracra-
nial implantation of guide cannulae and recovery, these rats were main-
tained at 90% of their free-feeding body weights and trained to
self-administer food pellets by pressing a lever under a FR4 schedule.
Effects on food-reinforced responding were tested after stable patterns of
lever pressing were observed (10% variation from the mean over 3
sessions).
Histological confirmation of injection sites
The accuracy of cannula implantation was confirmed postmortem in
each rat after cardiac perfusionwith 60ml 0.15%NaCl followed by 60ml
of 2.5% buffered neutral formalin under sodium pentobarbital anesthe-
sia (55mg/kg). Brains were removed and stored in 2.5% buffered forma-
lin before vibratome sectioning (40 m), slide mounting, and staining
with cresyl violet for examination using a light microscope. Rats with
injection sites outside of the VTA or the vBNSTwere excluded from data
analysis.
Experiment 1: effects of intra-BNST  AR antagonists on stress-
induced reinstatement
We initially examined the role of-1 and-2AR activation in the vBNST
in stress-induced reinstatement by testing rats for shock-induced rein-
statement following bilateral intra-vBNST injection of the -1 AR selec-
tive antagonist, betaxolol (1 nmol/307 ng per side), the -2 AR
antagonist selective antagonist, ICI-118,551 (1 nmol/277 ng per side) or
vehicle (sterile water). Concentrations were selected based on selectivity
for human  receptor subtypes (Baker, 2005). Moreover, the antagonist
concentrations were previously used to selectively target brain  ARs
(Delfs et al., 2000; Leri et al., 2002; Cecchi et al., 2007; LaLumiere et al.,
2010). Rats received vBNST injections 15 min before shock. Nine total
rats were used for this experiment. Five rats were tested for shock-
induced reinstatement following pretreatment with vehicle, betaxolol,
and ICI-118,551; two rats were tested following only vehicle and betax-
olol; and two rats were tested for following only vehicle and ICI-118,551.
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An additional group of rats (n  6) was tested for the effects of ICI-
118,551 and vehicle on food-reinforced lever pressing.
Experiment 2: reinstatement by intra-vBNST injection of
-AR agonists
To further examine the role of vBNST-1 and-2 ARs in stress-induced
cocaine seeking, a separate group of rats was tested for the ability of
bilateral intra-vBNST injection of the -1 AR selective agonist dobut-
amine (1 nmol/ 301 ng per side) or the -2 AR selective agonist clenb-
uterol (36 pmol/10 ng per side) to induce reinstatement. Concentrations
were again chosen based on selectivity for human  receptor subtypes
(Baker, 2010). Further, the clenbuterol dose has been previously used to
selectively target brain-2ARs (Roozendaal et al., 2008; LaLumiere et al.,
2010). Ten total rats were used for this experiment. Seven rats were tested
for reinstatement in response to dobutamine, clenbuterol, and vehicle.
An additional three rats were tested only with clenbuterol and vehicle.
Experiment 3: effect of VTA CRF receptor antagonism on
stress-induced reinstatement
To confirm our earlier finding that shock-induced reinstatement re-
quires CRF receptor activation in the VTA (Blacktop et al., 2011), we also
tested rats for the effects of intra-VTA pretreatment with the CRF-R1
receptor antagonist, antalarmin (Webster et al., 1996; 1.32 nmol/500
ng/side). We (Blacktop et al., 2011) and others (Lowery-Gionta et al.,
2012) have used this antalarmin dose to investigate CRF-R1 receptor-
dependent contributions to behavior. Six rats were used for this experi-
ment. Each of them was tested for the effects of both antalarmin and
vehicle on shock-induced reinstatement
Experiment 4: identification of CRF-positive neurons in the
vBNST that project to the VTA
Retrograde tracing using CTb.We used cholera toxin B subunit (CTb) as
a retrograde tracer to identify neurons in the vBNST with direct efferent
projections to the VTA. Rats were anesthetized with ketamine and xyla-
zine and placed in a stereotaxic frame. Heat-sterilized Hamilton syringes
were used to pressure inject 0.2 l biotinylated CTb (List Biological
Laboratories) unilaterally into the VTA over a 10 min period (posterior
to bregma 5.6 mm, lateral 2.6 mm, ventral 8.6 mm; Paxinos and
Watson, 2006). Syringes were left in place for 20 min after injections and
slowly removed from the brain over a 10 min period.
Colchicine treatment. Because it has been reported that inhibition of
axonal transport using pretreatment with the microtubule polymer-
ization inhibitor colchicine is necessary for detection of CRF-
immunoreactive cell bodies within the vBNST (Sakanaka et al., 1986)
anesthetized rats received injections of colchicine (1.25mol/500g in 2
l) into a lateral ventricle (posterior to bregma1.0mm, lateral 1.4mm,
ventral5.3 mm) 10 d after injection with CTb, thus avoiding interfer-
ence with retrograde transport of CTb.
Tissue collection and preparation. Twenty-four hours after the colchi-
cine injections, rats were anesthetized with sodium pentobarbital (55
mg/kg, i.p.) and perfused transcardially with 30 ml of 0.9% NaCl, fol-
lowed by 60 ml of cold (4°C) 4% paraformaldehyde in 0.1 M phosphate
buffer, pH 7.0. Brains were quickly removed and immersed in fixative for
24 h at 4°C. Brains were washed twice in 0.1 M sodium phosphate buffer
for 12 h each, after which they were cryoprotected in 30% sucrose in 0.1
M-phosphate buffer for 3 d at 4°C. Brains were rapidly frozen and serial
coronal sections (30 m) were cut on a cryostat. Sections were stored at
20°C until immunofluorescence procedures were conducted.
Fluorescence immunocytochemistry. Immunofluorescence for CTb and
CRFwas conducted on free-floating 30msections. Sectionswere rinsed
three times for 10 min in 0.05 M KPBS and once for 10 min in 0.1 M
glycine in 0.05 KPBS, followed by blocking in 3% normal donkey serum
in 0.4%Triton KPBS for 20min. Sections were then incubated for 48 h at
4°C with rabbit anti-CRF (supplied by DrWylie Vale, The Salk Institute)
diluted 1:8000 in 0.1% Triton KPBS with 3% normal donkey serum.
Sections were then rinsed 3 10 min in 0.05 M KPBS, followed by incu-
bation with an AlexaFluor 488-conjugated donkey anti-rabbit secondary
antibody (Catalog #A11008; 1:500; Life Technologies) in 0.05 MKPBS for
2 h at room temperature, and rinsed three times for 10 min in 0.05 M
KPBS. For detection of biotinylated CTb, sections were incubated for
24 h at 4°C in goat anti-biotin polyclonal antibody (Catalog # SP 3000;
Vector Laboratories) diluted 1:30,000 in 0.1% Triton KPBS and 3% nor-
mal donkey serum. After rinsing, sections were incubated 2 h with Alex-
aFluor 598-conjugated donkey anti-goat IgG (Catalog #A-110581; 1:500;
Life Technologies) and washed three times for 10 min in 0.05 M KPBS.
Sections were briefly rinsed in distilled water and mounted onto gel-
coated SuperFrost Plus slides and coverslipped usingVectashieldmount-
ing medium with DAPI (Catalog #H-1200; Vector Laboratories).
Photomicrographs were acquired using a Retiga 2000R digital camera
(QImaging) on a Nikon 80i microscope using NIS Elements software
(Nikon Instruments).
Experiment 5: effects of vBNST and VTA disconnection on stress-
induced cocaine seeking
A disconnection approach was used to determine whether a  2-AR
activated, CRF-dependent pathway between the vBNST and the VTA is
required for stress-induced cocaine seeking. At the time of catheteriza-
tion, separate groups of rats were implanted with two cannulae aimed
unilaterally at the vBNST and VTA in either the contralateral or the
ipsilateral hemisphere(s) of the brain. The effect of pathway disconnec-
tion was examined in six rats by injection of the -2 AR antagonist ICI
118,551 (1 nmol/277 ng) into the vBNST in one hemisphere and the
CRF-R1 receptor antagonist antalarmin (1.32 nmol/500 ng) into the
VTA of the other before testing for shock-induced reinstatement. For
comparison, the same rats were tested for shock-induced reinstatement
following injection of vehicle into each region. As a control to ensure that
reductions in reinstatement were attributable to disconnection, a second
groups of rats (n 7) received a unilateral injection of ICI 118,551 into
the vBNST in one hemisphere and a unilateral injection of antalarmin
into the VTA in the same hemisphere before testing for shock-induced
reinstatement. These rats were also tested for the effects of ipsilateral
vehicle injections. For this experiment, the hemispheres into which can-
nulae were implanted were randomized across rats in each group such
that in the contralateral treatment group, half of the rats received ICI
118,551 injections into the left vBNST and antalarmin injections into the
right VTA, whereas the other half received ICI 118,551 injections into the
right vBNST and antalarmin injections into the left VTA. Likewise, half
of the rats in the ipsilateral treatment group received drug injections into
sites in the right hemisphere, whereas the remaining rats received injections
into sites in the left hemisphere. To examine the potential contribution of
nonspecific behavioral suppression to the effects on reinstatement, an ad-
dition group of rats (n 6) was tested for the effects of contralateral drug
and vehicle injections on food-reinforced lever pressing.
Experiment 6: role of vBNST CRF-R1 receptors in cocaine seeking
induced by vBNST -2 AR activation
It has been reported that CRF-R1 antagonist injections directly into the
vBNST can also block stress-induced cocaine seeking (Erb and Stewart,
1999; Erb et al., 2001). To determine whether -2 ARs in the vBNST
regulate efferent pathways to the VTA to produce cocaine seeking via a
mechanism that also involves local CRF actions, we tested for the ability
of intra-BNST pretreatment with antalarmin to block reinstatement in
response to local delivery of the beta2 AR agonist clenbuterol. Reinstate-
ment in response to bilateral intra-BNST delivery of clenbuterol (36
pmol/10 ng per side) was examined following bilateral intra-BNST pre-
treatment with antalarmin (1.32 nmol/500 ng/side) or vehicle (10 min
pretreatment) in counterbalanced sequence in six rats. To test the hy-
pothesis that CRF-R1 receptor activation in the vBNST is downstream
from-2ARactivation in the sequenceof events thatmediate stress-induced
cocaine seeking, a separate group of six rats was tested for reinstatement in
response to bilateral intra-vBNSTCRF (63 pmol/300 ng/side; Erb and Stew-
art, 1999) following bilateral intra-vBNST pretreatment with the selective
-2 AR antagonist, ICI-118,551 (1 nmol/277 ng per side) or vehicle (10min
pretreatment).
Statistical analyses
Statistical analyses were conducted using Predictive Analytics SoftWare sta-
tistics software (SPSS). Statistical significance was determined using
ANOVA followed, when appropriate, by further analyses of main effects
using ANOVA and/or post hoc testing using Bonferroni-corrected t tests.
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Results
Cocaine SA and extinction in rats used for the various reinstate-
ment experiments are shown in Table 1 and did not differ across
experiments. In general, each group of rats displayed escalation,
as previously demonstrated under these conditions, and showed
reduced cocaine seeking across extinction testing, which con-
sisted of an average of 8.24 (0.28) sessions before extinction
criteria were met. The injection sites for rats used for each exper-
iment are depicted in Figure 1. A total of 11 rats were excluded
from analyses due to cannula misplacement. In all cases, drug
effects were not observed with inaccurate injections.
Experiment 1: effects of intra-BNST  AR antagonists on
stress-induced reinstatement
The effect of bilateral intra-vBNST injection of the-1 AR antag-
onist betaxolol (1 nmol/307 ng per side) on shock-induced rein-
statement was examined in seven rats and is shown in Figure
2A. Two-way repeated measures (reinstatement  betaxolol)
ANOVA showed a significant overall reinstatement effect (F(1,6)
 65.437; p  0.001) but no main effect of betaxolol pretreat-
ment or interaction between betaxolol treatment and reinstate-
ment. Shock produced robust reinstatement regardless of
whether rats were pretreatedwith betaxolol or vehicle. The effects
of bilateral intra-vBNST injection of the -2 AR antagonist ICI-
118,551 (1 nmol/277 ng per side) pretreatment on shock-induced
reinstatement were also examined in seven rats and are shown in
Figure 2B. Two-way repeated-measures ANOVA showed a sig-
nificant reinstatement effect (F(1,6)  52.475; p  0.001) and a
significant main effect of ICI-118,551 pretreatment (F(1,6) 
10.224; p  0.05), as well as a significant reinstatement  ICI-
118,551 pretreatment interaction (F(1,6)  20.213; p  0.01).
Shock reinstated cocaine seeking in vehicle but not ICI-118,551
pretreated rats (p  0.01 vs extinction; Ext) and reinstatement
was reduced in ICI-118,551 pretreated versus vehicle pretreated
rats (p 0.01). To assess potential motor impairment resulting
from intra-vBNST ICI-118,551 delivery that may have nonspe-
cifically interfered with reinstatement responding, a separate
groupof six ratswas tested for effects of intra-vBNST ICI-118,551
on sucrose pellet-reinforced responding. ICI-118,551 pretreat-
ment failed to alter lever pressing under these conditions (Fig.
2C). In three of the rats that were tested, guide cannulae were
misplaced such that they received injections into areas that com-
prise the dorsal BNST. Notably, in these rats, shock-induced re-
instatement was observed in both vehicle-pretreated (Ext: 8.67
1.76 responses vs shock: 32.33  2.03) and ICI-118,551-
pretreated (Ext: 12.67  1.76 responses vs shock: 28.33  4.81)
rats. Effects of shock were specific to the previously active lever as
shock failed to increase responding on a previously inactive lever
in vehicle-pretreated rats (Ext: 1.37  0.51 responses vs shock:
1.02 0.44). Neither betaxolol nor ICI-118,551 affected inactive
lever responding during reinstatement testing (vehicle: 1.02 
0.44 responses; betaxolol: 1.00 0.33; ICI-118,551: 0.75 0.31).
Experiment 2: reinstatement by intra-vBNST injection of
-AR agonists
Following SA and extinction, bilateral intra-vBNST delivery of
clenbuterol (36 pmol/10 ng per side) but not dobutamine (1
nmol/ 301 ng per side), reinstated cocaine seeking (Fig. 3). A
paired t test showed that, compared with vehicle, pretreatment
with clenbuterol significantly increased previously active lever
pressing (t(9) 11.156; p 0.001). Neither dobutamine (0.88
0.22 responses) nor clenbuterol (0.83  0.55 responses) in-
creased responding on a previously inactive lever relative to ve-
hicle pretreatment (0.63 0.18) responses. Guide cannulae were
misplaced in three rats such that they received injections into sites
within the dorsal BNST. In contrast to rats that received intra-
vBNST injections, neither clenbuterol (Ext: 8.67 1.99 vs clen-
buterol: 5.33  5.95) nor dobutamine (Ext: 10.00  2.07 vs
dobutamine: 9.33 7.60) produced reinstatement in these rats.
Experiment 3: effect of VTA CRF receptor antagonism on
stress-induced reinstatement
As previously reported (Blacktop et al., 2011), bilateral injection
of the CRF-R1 receptor selective antagonist, antalarmin (1.32
nmol/500 ng per side) into the VTA prevented reinstatement.
The effect of bilateral intra-VTA antalarmin pretreatment on
shock-induced reinstatement was examined in six rats as shown
in Figure 4. Two-way repeated-measures ANOVA showed a sig-
nificant reinstatement effect (F(1,5)  12.971; p  0.05) and a
significant main effect of antalarmin pretreatment (F(1,5) 
9.175; p  0.05), as well as a significant reinstatement  anta-
larmin pretreatment interaction (F(1,5)  8.461; p  0.05). As
previously reported, shock reinstated cocaine seeking in vehicle
but not antalarmin pretreated rats (p  0.05 vs Ext) and rein-
statement was reduced in antalarmin pretreated versus vehicle
pretreated rats (p 0.05). As we have already demonstrated that
intra-VTA antalarmin delivery does not alter food-reinforced le-
ver pressing (Blacktop et al., 2011), we did not test for these
effects in this study. In two of the rats that were tested, guide
cannulae were misplaced such that they received injections out-
side of the VTA. Notably, in these rats, shock-induced reinstate-
ment was observed in both vehicle-pretreated (Ext: 13 and 12
responses vs shock: 35 and 29 responses) and antalarmin-
pretreated (Ext: 5 and 12 responses vs shock: 39 and 41 responses)
rats. Effects of shock were specific to the previously active lever as
shock failed to increase responding on a previously inactive lever
in vehicle-pretreated rats (Ext: 1.12  0.29 responses vs shock:
0.89 0.65). Antalarmin did not affect inactive lever responding
during reinstatement testing (vehicle: 0.89  0.65 responses;
antalarmin: 0.81 0.52).
Experiment 4: identification of CRF-positive neurons in the
vBNST that project to the VTA
To determine whether CRF-positive neurons within the vBNST
project to the VTA, we injected CTb unilaterally into the VTA
and looked for the presence of CTb/CRF double-labeled per-
ikarya in the vBNST in four rats. Representative photomicro-
graphs from one rat are shown in Figure 5. CTb-immunoreactive
(CTb-ir) perikarya were observed in the vBNST ipsilateral, to the
VTA injection site (average of 45 CTb-ir perikarya/ipsilateral
vBNST). By contrast, and consistent with a previous report
(Dong and Swanson, 2006), CTb immunoreactivity in the
vBNST contralateral to the VTA injection site was minimal (av-
erage of four immunoreactive cells/contralateral vBNST). CRF-
Table 1. Cocaine SA and extinction
Experiment no. (n)
Cocaine SA Extinction
SA day 1 SA day 14 First Ext Last Ext
1 (9) 77.22 7.71 92.78 8.19 66.33 11.50 9.89 2.35
2 (10) 68.57 8.36 89.38 7.07 104.20 24.21 9.70 1.14
3 (6) 75.10 5.86 90.21 7.26 70.20 29.14 11.60 1.47
5 (13) 71.82 4.73 85.74 4.01 68.09 12.83 12.00 2.39
6 (12) 74.00 4.82 82.00 3.44 129.62 16.09 8.38 1.21
Data represent cocaine SA (infusions/6 h session SE) on days 1 and 14 of SA testing and cocaine lever responding
(responses/2 h session SE) on the first day of extinction training (First Ext) and the last day of extinction training
prior to reinstatement testing (Last Ext) in rats from each of the reinstatement experiments.
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like-immunoreactive (CRF-ir) perikarya and fibers were
observed in the vBNST (Fig. 5). Under higher-magnification,
three cell types were observed in the vBNST: CTb-ir/CRF-
immunonegative, CTB-ir/CRF-ir, and CTb-immunonegative/
CRF-ir cells. Notably, most CRF-positive cells in the ipsilateral
vBNST were also CTb-immunoreactive (80%). By contrast,
dual-labeled CRF- and CTb-positive cells were not observed in
the contralateral vBNST.
Figure 1. Intracranial injection sites. Representative atlas diagrams (Paxinos andWatson, 2006) of injection sites within the vBNST and the VTA. A, Rats from Experiments 1, 2 and 5; vBNST hits
are depicted as circles and misses as triangles. B, Food control rats for Experiment 1; hits are depicted as squares and misses as triangles. C, Rats from Experiment 3; VTA hits are depicted as circles
and misses as triangles. D, Rats used for the Experiment 4; contralateral hits are depicted as circles, ipsilateral hits are depicted as squares and food-controls are depicted as triangles.
Figure2. Footshock-induced reinstatementof cocaine seeking is blockedby intra-vBNST injectionof the-2ARantagonist, ICI-118,551, butnot the-1ARantagonist, betaxolol. Data represent
theeffectsofbilateral intra-vBNST injectionsofbetaxolol (1nmol/307ngperside;A;n7)or ICI-118,551(1nmol/277ngperside;B;n7)orvehicleonreinstatement(responses/2hsessionSE)byelectric
footshock. Significant reinstatementwas observed following intra-vBNST pretreatmentwith vehicle or betaxolol (*p 0.05 vs Ext), but not ICI-118,551. Likewise, responding following ICI-118,551, but not
betaxolol,was significantly reduced comparedwith vehicle pretreatment ( #p 0.05 vs vehicle). By contrast, intra-vBNST ICI-118,551 failed to altered food-reinforced lever pressing (C;n 6).
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Experiment 5: effects of vBNST and VTA disconnection on stress-
induced cocaine seeking
To determine the role of a -2 AR regulated pathway originating
in the vBNST that releases CRF into the VTA in stress-induced
cocaine seeking, we used a disconnection approach in which we
delivered ICI-118,551 (1 nmol/277 ng) into the vBNST of one
hemisphere and antalarmin (1.32 nmol/500 ng) into the con-
tralateral VTA (n  6 rats). To confirm that any effect on rein-
statement was attributable to pathway disconnection, a second
group of rats (n 5) received ICI-118,551 into the vBNST of one
hemisphere and antalarmin into the ipsilateral VTA. Contralat-
eral but not ipsilateral antagonist delivery prevented shock-
induced reinstatement (Fig. 6A), suggesting that, during stress,
-2 AR in the vBNST regulate one or more pathways that release
CRF into the VTA to induce cocaine seeking. A three-way
ANOVA showed a significant interaction between reinstatement
test condition (shock vs extinction; repeated measure), antago-
nist pretreatment (ICI-118,551/antalarmin vs vehicle/vehicle
treatment; repeated measure), and injection site (contralateral vs
ipsilateral; between-subjects; F(1,9)  7.169; p  0.05). Further
analysis revealed a significant interaction between antagonist
treatment and shock-induced reinstatement only in rats that re-
ceived contralateral antagonist injections (F(1,5)  25.851; p 
0.01). Post hoc testing showed that significant shock-induced
reinstatement was observed following vBNST/VTA vehicle (con-
tralaterally or ipsilaterally) and following ipsilateral intra-vBNST
ICI-118,551 and intra-VTA antalarmin pretreatments (p 0.05
for each comparison) but not following contralateral antagonist
delivery. Furthermore, shock-induced reinstatement was signifi-
cantly reduced following contralateral antagonist injections rela-
tive to either vehicle pretreatment or ipsilateral antagonist
delivery (p  0.05 for each comparison). To assess potential
motor impairment resulting from the disconnection approach
that may have nonspecifically interfered with reinstatement re-
sponding, a separate group of six rats were tested for effects on
sucrose pellet-reinforced responding. Contralateral intra-vBNST
ICI-118,551 and intra-VTA antalarmin delivery failed to alter
lever pressing under these conditions (Fig. 6B). Effects of shock
were specific to the previously active lever as shock failed to in-
crease responding on a previously inactive lever in vehicle/
vehicle-pretreated rats (Ext: 0.88  0.35 responses vs shock:
1.11 0.27). Neither ipsilateral nor contralateral manipulations
affected inactive lever responding during reinstatement testing
(vehicle/vehicle: 1.11  0.27 responses; ipsilateral: 0.97  0.66;
contralateral: 0.93 0.66).
Experiment 6: role of vBNST CRF-R1 receptors in cocaine seeking
induced by vBNST -2 AR activation
Because it has been reported that CRF receptors in the BNST are
also required for stress-induced cocaine seeking (Erb and Stew-
art, 1999; Erb et al., 2001), and because BNST  ARs have been
proposed to modulate efferent projections to the VTA via regu-
lation of local CRF actions (Silberman et al., 2013), we hypothe-
sized that reinstatement induced by vBNST -2 AR activation
requires local CRF receptor activation. To test this hypothesis we
delivered antalarmin (1.32 nmol/500 ng per side) bilaterally into
the vBNST before bilateral vBNST injection of clenbuterol (36
pmol/10 ng per side). As shown in Figure 7, intra-vBNST anta-
larmin delivery prevented intra-vBNST clenbuterol-induced co-
caine seeking (n  7). Two-way repeated-measures ANOVA
showed a significant reinstatement effect (F(1,6)  25.910; p 
0.01) and a significant main effect of antalarmin pretreatment
(F(1,6)  29.883; p  0.01), as well as a significant reinstate-
ment  antalarmin pretreatment interaction (F(1,6)  35.968;
p  0.01). Clenbuterol reinstated cocaine seeking in vehicle but
not antalarmin-pretreated rats (p  0.01 vs Ext) and reinstate-
Figure 4. Bilateral injection of the CRF receptor antagonist, antalarmin, into the VTA prevents
shock-induced reinstatement of cocaine seeking. Data represent the effects of bilateral intra-vBNST
delivery of antalarmin (1.32 nmol/500 ng per side; Fig. 2A; n 6) or vehicle on reinstatement (re-
sponses/2h sessionSE) followingelectric footshock. Significant reinstatementwasobservedafter
intra-vBNST pretreatmentwith vehicle (*p 0.05 vs Ext) but not antalarmin. Likewise, responding
following antalarminwas significantly reduced comparedwith vehicle pretreatment ( #p 0.05).
Figure3. Reinstatementof extinguished cocaine seekingbybilateral injectionof the-2AR
selective agonist, clenbuterol, but not the -1 AR selective agonist, dobutamine, into the
vBNST. Data represent responding on the cocaine lever (responses/2 h session SE; active) or
a previously inactive lever. Intra-vBNST clenbuterol (36 pmol/10 ng per side; n 10), but not
dobutamine (1 nmol/301 ng per side; n 7) reinstated extinguished cocaine seeking (*p
0.05 vs vehicle). Neither dobutamine nor clenbuterol increased “inactive” lever responding.
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ment was reduced in antalarmin- versus
vehicle-pretreated rats (p  0.01). By
contrast, bilateral intra-vBNST pretreat-
ment with the -2 AR antagonist, ICI-
118,551 (1 nmol/277 ng per side) failed to
attenuate reinstatement in response to
intra-vBNST CRF delivery (63 pmol/300
ng per side). Two-way repeated-measures
ANOVA showed an overall effect of CRF
(F(1,5)  46.925) but no overall effect of
ICI-118,551 pretreatment or no CRF 
ICI-118,551 interaction. Altogether, these
findings indicate that CRF receptor acti-
vation is likely downstream from -2 AR
activation in the sequence of events re-
sponsible for stress-induced reinstate-
ment. Effects of intra-BNST clenbuterol
(2.14 0.67 responses vs 1.38 0.73 re-
sponses during extinction) and CRF
(0.66 0.42 vs 0.00 0.00 responses dur-
ing extinction) on previously inactive le-
ver responding were not observed.
Likewise, neither intra-BNST antalarmin
(antalarmin/clenbuterol: 1.16  0.16 re-
sponses) nor intra-BNST ICI-118,551
(ICI/CRF: 2.5  1.93 responses) signifi-
cantly altered inactive lever pressing dur-
ing reinstatement.
Discussion
Our results extend earlier findings that the
reinstatement of cocaine seeking by a
stressor, electric footshock, requires CRF
actions in the VTA (Wang et al., 2005;
Blacktop et al., 2011) and vBNST  AR
activation (Leri et al., 2002) by showing
that vBNST -2 AR activation is both
necessary and sufficient for stress-induced
reinstatement. Moreover, using a discon-
nection approach in which we block -2
ARs in the vBNST of one hemisphere and
VTA CRF-R1 receptors in the contralat-
eral hemisphere, we demonstrate that
vBNST -2 ARs regulate a CRF-releasing
pathway to the VTA that is necessary for
stress-induced cocaine seeking. As VTA
CTb delivery labels CRF-positive cells in
the ipsilateral vBNST, it is likely that this pathway consists (at
least partly) of vBNST CRF neurons that project directly to the
VTA. Consistent with reports that CRF actions in the BNST are
required for stressor-induced cocaine seeking (Erb and Stewart,
1999; Erb et al., 2001), we demonstrate that vBNST CRF-R1 ac-
tivation is necessary for reinstatement induced by local delivery
of the -2 AR agonist, clenbuterol, suggesting that -2 AR-
mediated activation of this BNST-to-VTA pathway also requires
local CRF receptor activation.
Findings from laboratory studies in human cocaine addicts
(Jobes et al., 2011) and preclinical experiments in rodents (Erb et
al., 2000; Mantsch et al., 2010) point to a role for noradrenergic
signaling in the stress-induced relapse to cocaine use. Specifically,
our studies in mice suggest that -2 ARs are critical for stress-
induced cocaine seeking (Vranjkovic et al., 2012). As a target for
ascending noradrenergic projections (Ricardo and Koh, 1978;
Weller and Smith, 1982; Woulfe et al., 1990) and a key site for
integration of stress and reward networks (Flavin and Winder,
2013; Stamatakis et al., 2014), the BNST is a likely location at
which stress-induced increases in norepinephrine regulate drug
use. Although shock-induced increases in norepinephrine have
not been reported, a variety of distinct stressors, including immo-
bilization (Pacak et al., 1995), visceral pain (Deyama et al., 2009),
and exposure to a shock-conditioned stimulus (Onaka and Yagi,
1998), fox odor (Fendt et al., 2005), or an aversive tastant (Park et
al., 2012), have been demonstrated to increase noradrenergic
neurotransmission in theBNST. In particular, the vBNST receives very
dense noradrenergic innervation (Woulfe et al., 1988; Georges and
Aston-Jones, 2001; Egli et al., 2005).Moreover, delivery of amixture of
-1 and-2 AR antagonists into the vBNST has been reported to pre-
vent shock-induced reinstatement in rats (Leri et al., 2002). Our data
extend these findingsbydemonstrating that-2butnot-1ARactiva-
Figure 5. CRF neurons within the vBNST project to the VTA. A, Line drawing (adapted from Paxinos and Watson, 2006) of a
coronal section containing the area of the VTA targeted for CTb microinjections and depicted in B. B, Representative photomicro-
graph depicting the VTA in brightfield, and CTb immunofluorescence in red. C, Line drawing of a coronal section containing the
vBNST used for immunostaining of CRF and CTb. D–G, Representative photomicrographs depicting immunostaining for CRF
(green) and CTb (red) in the BNST ipsilateral to the VTA injection site. Rectangle inD indicates area shown at higher-magnification
in E. E, White arrowheads indicate CRF-ir/CTb-ir (VTA-projecting) neurons; white arrows indicate CTb-ir/CRF-immunonegative
neurons; black arrowhead indicates a CRF-ir/CTb-immunonegative cell. Rectangles in E represent areas shown at higher-
magnification in indicatedpanels.F, CRF-ir/CTb-ir neurons in vBNST.G, CRF-positive/CTb-immunonegative cell inBnST. Scale bars:
B,D, 500m; E, 100m; F,G, 33m. ac, Anterior commissure; Aq, cerebral aqueduct; f, fornix; fr, fasciculus retroflexus; Fu, bed
nucleus of the stria terminalis, fusiform part; PAG, periaqueductal gray; PBP, parabrachial pigmented nucleus of the VTA; SN,
substantia nigra; STLV, bed nucleus of the stria terminalis, lateral division, ventral part; STMV, bed nucleus of the stria terminalis,
medial division, ventral part.
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tion in the vBNST is necessary for shock-induced cocaine seeking and
that intra-vBNST injection of a -2 AR- but not a -1 AR-selective
agonist is sufficient to reinstate.
Beta-2 ARs are expressed throughout the BNST (Cecchi et al.,
2007). Whereas in the dorsal BNST  AR activation can have
either excitatory or inhibitor effects on synaptic transmission, 
AR effects in the vBNST are predominantly inhibitory (Egli et al.,
2005) and include inhibition of neurons that project directly to
the VTA (Dumont and Williams, 2004). In the dorsal BNST,
-AR regulation of neuronal activity requires CRF-R1 activation
(Nobis et al., 2011). Although the involvement of CRF in
norepinephrine-dependent effects in the
vBNST has not been established, our find-
ing that local antalarmin pretreatment
blocks reinstatement by intra-vBNST
clenbuterol delivery supports a role for lo-
cal CRF actions in the regulation of co-
caine seeking by norepinephrine and -2
AR activation. Consistent with this possi-
bility, previous studies demonstrated that
(1) noradrenergic terminals synapse on
the dendrites of CRF-positive neurons
in the vBNST (Phelix et al., 1994), (2)
-2 AR-mediated reinstatement requires
CRF-R1 activation (McReynolds et al.,
2014), and (3) the-2 AR antagonist, ICI-
118,551, blocks stress-induced increases
of BNST CRF mRNA (McReynolds et al.,
2014). Overall, the findings are consistent
with reports that cocaine seeking induced
by central norepinephrine delivery is
blocked by CRF receptor antagonism,
whereas suppression of noradrenergic
function using the -2 AR agonist, cloni-
dine, does not affect reinstatement in re-
sponse to central CRF delivery (Brown et
al., 2009).
Notably, the magnitude of cocaine
seeking in response to intra-vBNST clen-
buterol was lower than that observed fol-
lowing either shock or CRF. This could be
attributed to (1) secondary effects of
BNST -2 AR activation that are not en-
gaged by shock or CRF and offset respond-
ing, (2) unique attributes of clenbuterol
itself (e.g., pharmacokinetics, ligand-speci-
fic receptor desensitization), or (3) the re-
quirement for additional stress-responsive
mediators to fully engage the processes that
lead to cocaine seeking.
Our findings suggest that the vBNST
influences cocaine seeking via regulation
of the VTA. Consistent with this possibil-
ity, stress-induced reinstatement in mice
is associated with activation of VTA-
projecting BNST neurons (Briand et al.,
2010) and a role for a vBNST-VTA path-
way in the expression of cocaine seeking
has been reported (Sartor and Aston-
Jones, 2012). In light of these findings, it is
surprising that vBNST -ARs have been
found to exert inhibitory effects on neu-
rons that project to the VTA, likely via
stimulation of local GABA release (Dumont andWilliams, 2004).
Both GABAergic and glutamatergic projections from the BNST
to the VTA have been identified (Georges and Aston-Jones, 2001,
2002; Kudo et al., 2012; Jennings et al., 2013). Moreover, CRF-
positive terminals within the VTA coexpress either the glutama-
tergic neuronal marker, vesicular glutamate transporter 2, or the
GABAergic neuronal marker, glutamic acid decarboxylase, and
make contacts that have morphological characteristics of either
excitatory or inhibitory synapses, suggesting that CRF can be
coreleased into the VTA along with either GABA or glutamate
(Tagliaferro and Morales, 2008). Further investigation is needed
Figure6. Disconnection of a-2AR-regulated vBNST-to-VTACRF-releasingpathwayprevents stress-induced cocaine seeking.
To determine the role of a -2 AR regulated pathway originating in the vBNST that releases CRF into the VTA in stress-induced
cocaine seeking, we used a disconnection approach in which we delivered ICI-118,551 into the vBNST of one hemisphere and
antalarmin into the contralateral VTA (n 6 rats) and tested for shock-induced cocaine seeking. To confirm that any effect on
reinstatementwas attributable topathwaydisconnection, a secondgroupof rats (n5) receivedan ICI-118,551 injection into the
vBNST of one hemisphere and an antalarmin injection into the ipsilateral VTA. Significant shock-induced reinstatement was
observed followingvBNST/VTAvehicle (contralaterally or ipsilaterally) and following ipsilateral intra-vBNST ICI-118,551/intra-VTA
antalarmin pretreatment (*p 0.05 vs Ext) but not following contralateral antagonist delivery (A). Furthermore, shock-induced
reinstatement was significantly reduced following contralateral antagonist injections relative to either vehicle pretreatment or
ipsilateral antagonist delivery ( #p 0.05 for each comparison). By contrast, contralateral antagonist injections failed to altered
food-reinforced lever pressing (B; n 6).
Figure7. Reinstatement of cocaine seekingby intra-vBNST clenbuterol injection requires activationof vBNSTCRF-R1 receptors.
Data represent the effects of A: bilateral intra-vBNST pretreatment with antalarmin (1.32 nmol/500 ng per side) or vehicle on
reinstatement (responses/2 h session SE) in response to bilateral intra-vBNST clenbuterol injection (36 pmol/10 ng per side), or
B: bilateral intra-vBNST pretreatment with ICI-118,551 (1 nmol/277 ng per side) or vehicle on reinstatement in response to
bilateral intra-vBNST CRF injection (63 pmol/300 ng per side). Significant clenbuterol-induced reinstatement was observed in
vehicle but not antalarmin pretreated rats (*p 0.05 vs Ext). Responding following antalarmin was significantly reduced com-
paredwithvehiclepretreatment ( #p0.05). By contrast, significant CRF-induced reinstatementwasobserved inbothvehicle and
ICI-118,551 pretreated rats (*p 0.05 vs Ext) and did not significantly differ between the two pretreatment conditions.
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to (1) confirm the neurochemical phenotype of VTA-projecting
vBNSTCRF-positive neurons, (2) clarify themechanism through
which -2 ARs regulate these neurons and determine how this
regulation might change following cocaine exposure, and (3) ex-
amine the likelihood that -2 AR in the vBNSTmay also regulate
CRF and/or CRF actions in the VTA via parallel multisynaptic
pathways. Consistent with the last possibility, BNST efferents can
influence the VTA through multisynaptic pathways that include
regions, such as the lateral habenula and rostromedial tegmental
area (Dong and Swanson, 2006; Kaufling et al., 2009; Lammel et
al., 2012).
It has been found that (1) shock elevates VTA CRF levels
(Wang et al., 2005), (2) intra-VTA CRF delivery is sufficient to
induce cocaine seeking (Wang et al., 2005; Blacktop et al., 2011),
and (3) VTA CRF receptor activation is required for stress-
induced reinstatement (Wang et al., 2005; Blacktop et al., 2011)
in rats. Our demonstration that intra-VTA antalarmin delivery
prevents shock-induced reinstatement is consistent with these
reports. As the antalarmin dose used may also block CRF-R2
receptors, our findings are not definitive regarding which CRF
receptor subtype is involved. However, we have reported that, in
rats tested under identical conditions, intra-VTA delivery of a
CRF-R2-selective antagonist does not prevent shock-induced re-
instatement, whereas intra-VTA injection of a CRF-R1 but not a
CRF-R2-selective agonist is sufficient to induce cocaine seeking
(Blacktop et al., 2011).
CRF actions in the VTA are complex and involve both excit-
atory and inhibitory effects that vary depending on the receptor
and site (Ungless et al., 2003; Riegel andWilliams, 2008;Wanat et
al., 2008; Beckstead et al., 2009; Hahn et al., 2009; Wanat et al.,
2013). Likely VTA targets for CRF include mesocortical DA cells,
which are activated during stress (Deutch et al., 1991). Elevated
medial prefrontal cortex DA, via activation of DA receptors, is
necessary for stress-induced reinstatement (Capriles et al., 2003;
McFarland et al., 2004). We demonstrate that the mechanisms
through which vBNST -2 ARs regulate this CRF projection to
the VTA requires local CRF actions, likely at CRF-R1. This find-
ing is consistent with reports that (1) depolarization of BNST
neurons by the nonselective-AR agonist, isoproterenol, is CRF-
dependent (Nobis et al., 2011), (2) CRF in the BNST depolarizes
neurons that project to the VTA (Silberman et al., 2013), and (3)
stress-induced increases in CRF mRNA in the BNST in mice are
-2 AR-dependent (McReynolds et al., 2014).Moreover it is con-
sistentwith reports that intra-BNST antalarmin delivery prevents
stress-induced cocaine seeking (Erb and Stewart, 1999; Erb et al.,
2001). Although the requirement for vBNST CRF is evident, the
source of this CRF has not been identified and could include
intrinsic cell populations within the BNST and/or CRF-releasing
projections originating in other regions (e.g., the central
amygdala). A clearer mechanistic understanding awaits determi-
nation of BNST-2AR receptor localization as it relates to that of
CRF and CRF-R1.
Although it is likely that themechanisms throughwhich stress
promotes relapse are not identical across drug classes, both
CRF-R1 receptor activation (Shaham et al., 1997; Leˆ et al., 2000;
Bruijnzeel et al., 2009) and central noradrenergic signaling (Erb
et al., 2000; Shaham et al., 2000; Leˆ et al., 2005; Yamada and
Bruijnzeel, 2011) are necessary for stress-induced reinstatement
of heroin-, nicotine-, and alcohol-seeking in rats. Moreover, in
the case of heroin, stress-induced drug seeking requires CRF
(Wang et al., 2006) and noradrenergic (Wang et al., 2001) signal-
ingwithin the BNST.Notably, similar processes in the BNSTmay
be engaged during withdrawal from ethanol (Francesconi et al.,
2009; Huang et al., 2010; Silberman et al., 2013) and opioids
(Delfs et al., 2000; Fuentealba et al., 2000), suggesting that this
pathway to the VTA, or parallel pathways originating in other
BNST subregionsmay also contribute towithdrawal-related drug
seeking.
To summarize, we report that, during stress, norepinephrine
released into the vBNST activates -2 ARs, which via a CRF-
dependent process, activate neurons that release CRF into the
VTA, thereby leading to cocaine seeking. Identification of the
processes responsible for stress-induced cocaine seeking should
guide the development of new treatment approaches aimed at
managing relapse, particularly in individuals whose use is
stress-related.
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